Skip to content

News & calendar

news: as of 2026-10-12
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-12

Mon · 12 Oct · today

Tue · 13 Oct

Behind

published · newest first

Mon · 13 Jul

partnership

07:43
Google News: Rheinmetall AG

Rheinmetall to Receive Nearly EUR1 Billion From UK Army Training Contract

Rheinmetall will receive close to EUR1 billion from a UK Army training contract.

Markets open original ↗

earnings

06:32
Google News: Nautilus Biotechnology

Nautilus Biotechnology Q1 2026 Earnings: EPS Beat Softens Loss, but No Revenue Raises Questions

Nautilus Biotechnology reported a Q1 EPS beat that softened its loss, though the lack of revenue raised investor questions.

Markets open original ↗

funding

00:42
Google News: Sumitomo Electric Industries

[News] Sumitomo Electric to Raise InP Substrate Expansion Scale With JPY 18 Billion

Sumitomo Electric is raising the scale of its InP substrate expansion with a JPY 18 billion investment.

Markets open original ↗

Sun · 12 Jul

partnership

23:19
Google News: Takeda Pharmaceutical Company Limited

Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products

Takeda and the Indonesian government announced a collaboration to strengthen healthcare resilience and expand access to lifesaving plasma-derived medicines.

Markets open original ↗

product

21:02
Google News: Charles River Laboratories International, Inc.

Charles River Laboratories International (CRL) Expands AI Pathology Platform

Charles River Laboratories is expanding its AI pathology platform.

Markets open original ↗

The wire

everything that arrived · 7 days